Literature DB >> 36243896

Methylation detection of circulating tumor cell miR-486-5p/miR-34c-5p in the progression of colorectal cancer.

Guolei Li1, Xuhua Hu2, Guiying Wang2, Cuizhi Geng3.   

Abstract

AIMS: This study set out to examine the expression and methylation levels of miR-486-5p/miR-34c-5p and its mechanism of action based on the microRNA methylation level of circulating tumor cells (CTCs) in colorectal cancer (CRC) through clinical data and tissue detection.
METHODS: EGFR and EpCAM immunophospholipid magnetic spheres (EpCAM-IML/EGFR-IML) were synthesized by the thin film method to capture CTCs in peripheral blood. The expression of miR-486-5p/miR-34c-5p was detected via real-time fluorescent quantitative PCR (RT-PCR). Methylation-specific PCR was implemented to detect the methylation level of miR-486-5p/miR-34c-5p, and 5-Aza-dC was used for demethylation treatment to detect the effect of changes in methylation levels on the tumor cells development. Cell Counting Kit-8 (CCK-8) analysis, transwell assay, and flow cytometry were used to determine the effects of demethylation and overexpression on the proliferation, invasion, migration, and apoptosis of CRC cells.
RESULTS: The results showed that the expression and methylation levels of the miR-486-5p/miR-34c-5p isolated from CTCs were low and the methylation level was high in tumor cells and tissues. In CRC cell lines, demethylation and overexpression of miR-486-5p/miR-34c-5p could effectively inhibit the proliferation, invasion and migration of tumor cells, and facilitate tumor apoptosis (p < 0.05).
CONCLUSION: The constructed CTCs sorting system has characteristics of high specificity and high sensitivity, is a supplement to tissue samples, and has guiding significance for the clinical rational use of drugs and personalized therapy.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Circulating tumor cells (CTCs); Colorectal cancer (CRC); Methylation; miR-34c-5p; miR-486-5p

Year:  2022        PMID: 36243896     DOI: 10.1007/s12094-022-02973-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  4 in total

1.  miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4.

Authors:  Wei-Ping Bi; Min Xia; Xin-Jian Wang
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

Review 2.  Role of miR‑34 in gastric cancer: From bench to bedside (Review).

Authors:  Shengwei Xiong; Mingli Hu; Chenyu Li; Xiaodong Zhou; Hongxia Chen
Journal:  Oncol Rep       Date:  2019-08-16       Impact factor: 3.906

3.  [The prognostic impact of number-indexes of lymph nodes in stage N1c colorectal cancer patients].

Authors:  K X Xi; S Y Song; Z K Luo; Z G Sun; L Feng; H Z Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2022-05-24

4.  Corrigendum to "Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers" [Semin. Cancer Biol. 83 (2022) 556-569].

Authors:  Kuo Chen; Pengwei Lu; Narasimha M Beeraka; Olga A Sukocheva; SubbaRao V Madhunapantula; Junqi Liu; Mikhail Y Sinelnikov; Vladimir N Nikolenko; Kirill V Bulygin; Liudmila M Mikhaleva; Igor V Reshetov; Yuanting Gu; Jin Zhang; Yu Cao; Siva G Somasundaram; Cecil E Kirkland; Ruitai Fan; Gjumrakch Aliev
Journal:  Semin Cancer Biol       Date:  2022-07-16       Impact factor: 17.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.